含硫醚、硒醚及二硫键链接侧链的小檗碱衍生物的合成及体外抗肿瘤活性

为开发高效低毒的抗肿瘤天然产物衍生物,依据药物拼合原理设计并合成了10个新型小檗碱衍生物。将盐酸小檗碱与含单硫醚、单硒醚和二硫键脂肪链片段通过缩合反应得到目标化合物,其化学结构均经过核磁共振氢谱、碳谱以及高分辨质谱确证。采用噻唑蓝（MTT）法考察其体外抗肿瘤活性,结果表明,7个化合物针对不同的癌细胞株的抑制活性优于盐酸小檗碱,同时对人正常肝细胞L02的毒性较低。化合物3e的体外抗肿瘤活性最佳(针对BEL-7402的IC₅₀值为8.70μmol/L,选择性指数为3.61),可对其深入研究用以开发高效低毒的抗肿瘤药物。     

高选择性端粒G-四链体稳定性配体:9-O-多胺取代小檗碱衍生物的合成及活性评价

设计合成了3个多胺取代的小檗碱衍生物5a~5c, 并利用圆二色(CD)光谱、 荧光共振能量转移(FRET)熔点实验、 荧光光谱和聚合酶链反应(PCR)终止实验等手段研究了小檗碱衍生物5a~5c与端粒DNA的相互作用. 结果表明, 小檗碱衍生物5a~5c可以诱导端粒DNA序列形成反平行结构G-四链体, 显著地提高了端粒G-四链体的稳定性, 有效地抑制了端粒的扩增; 而与双链DNA的相互作用则很小, 是高选择性的端粒G-四链体配体.     

8-烷基小檗碱的合成

对比研究了乙醚、二氧六环和四氢呋喃(THF)三种溶剂对8位长链烷基取代小檗碱衍生物中间体合成产率的影响. 以四氢呋喃(THF)为反应溶剂, 8-癸基和8-月桂基盐酸小檗碱的产率是以乙醚为溶剂的4倍以上.     

含苹果酸酯的石蒜碱衍生物的合成及生物活性

以具有生理活性的石蒜碱为先导化合物, 设计、 合成了几种含取代苹果酸酯片段的石蒜碱衍生物. 所有新化合物均通过核磁共振波谱、 质谱、 旋光光谱及圆二色光谱进行了结构表征. 抗肿瘤活性初步研究结果表明, 含取代苹果酸酯的石蒜碱类似物在保持石蒜碱抗肿瘤活性的同时, 对正常细胞的毒性显著下降, 此结果为新型高效、 低毒石蒜碱类化合物的设计奠定了基础.     

白杨素衍生物的合成及生理活性研究进展

黄酮类化合物白杨素具有抗氧化、抗肿瘤、抗癌、抗病毒、抗高血压、抗糖尿病、抗菌、抗过敏等广泛的生理活性.近年来,许多国内外学者对其衍生物的合成及生理活性进行了研究,以期开发出活性更高,更具有临床应用价值的药物.本文着重对各类白杨素衍生物的合成及生理活性研究进展进行综述.     

5-氨基噻唑衍生物合成的研究进展

5-氨基噻唑衍生物具有很好的生理活性,其合成方法和生物生理活性研究已引起药物研发者的关注.综述了近几十年来有关5-氨基噻唑衍生物的合成方法.     

双氢青蒿素衍生物的研究进展

从醚类、酯类、杂原子取代C-10-O类等单活性基团衍生物和双活性基团衍生物两大类结构出 发,综述了1997后合成的双氢青蒿素衍生物及其合成方法,在生理活性研究方面发现双氢青蒿素衍生物除具有抗疟活性外,还具有抗肿瘤、抗血吸虫、抗孕、提高免疫力等其他生物与生理活性.     

亮点介绍

手性路易斯碱催化的α-乙酰氧基-β-烯胺酯的不对称氢化硅烷化反应:光学活性α-羟基-β-氨基酸衍生物的合成Angew.Chem.Int.Ed.2011,50,7304～7307光学活性的α-羟基-β-氨基酸片段广泛存在于天然产物以及生理活性物质中,是一类非常重要的化合物,其中最具代表性的就是紫杉醇侧链及其类似物.因此,光学活性α-羟基-β-氨基酸衍生物的合成引起了广泛而持久的兴趣,多年来众多研究小组发展了多种高效、高选择性的合成方法.最近,中国科学院成都有机化学研究所张晓梅等设计了一类α-乙酰氧基-β-烯胺酯底物1,并以新型路易斯碱催化剂2催化其不对称氢化硅烷化反应,以较高的对映选择     

含氟β-氨基酸及其衍生物的合成进展

含氟β-氨基酸及其衍生物具有特殊的生理活性, 其合成方法的研究近年来受到广泛关注. 以直接氟化法和间接氟化法分类, 概述了含氟β-氨基酸及其衍生物的合成方法及最新研究进展, 对一些已知化合物的生理活性及药用价值作了初步归纳.     

茄呢基氮芥衍生物的合成及生理活性

茄呢基氮芥衍生物的合成及生理活性;氮芥;茄呢醇;合成;生理活性     

Berberine Derivatives as Pseudomonas aeruginosa MexXY-OprM Inhibitors: Activity and In Silico Insights

The natural alkaloid berberine has been demonstrated to inhibit the Pseudomonas aeruginosa multidrug efflux system MexXY-OprM, which is responsible for tobramycin extrusion by binding the inner membrane transporter MexY. To find a structure with improved inhibitory activity, we compared by molecular dynamics investigations the binding affinity of berberine and three aromatic substituents towards the three polymorphic sequences of MexY found in P. aeruginosa (PAO1, PA7, and PA14). The synergy of the combinations of berberine or berberine derivatives/tobramycin against the same strains was then evaluated by checkerboard and time-kill assays. The in silico analysis evidenced different binding modes depending on both the structure of the berberine derivative and the specific MexY polymorphism. In vitro assays showed an evident MIC reduction (32-fold and 16-fold, respectively) and a 2–3 log greater killing effect after 2 h of exposure to the combinations of 13-(2-methylbenzyl)- and 13-(4-methylbenzyl)-berberine with tobramycin against the tobramycin-resistant strain PA7, a milder synergy (a 4-fold MIC reduction) against PAO1 and PA14, and no synergy against the ΔmexXY strain K1525, confirming the MexY-specific binding and the computational results. These berberine derivatives could thus be considered new hit compounds to select more effective berberine substitutions and their common path of interaction with MexY as the starting point for the rational design of novel MexXY-OprM inhibitors.     

Solution and Solid‐State Analysis of Binding of 13‐Substituted Berberine Analogues to Human Telomeric G‐quadruplexes

The interaction between 13‐phenylalkyl and 13‐diphenylalkyl berberine derivatives ( NAX ) and human telomeric DNA G4 structures has been investigated by both spectroscopic and crystallographic methods. NAX042 and NAX053 are the best compounds improving the performance of the natural precursor berberine. This finding is in agreement with the X‐ray diffraction result for the NAX053 ‐Tel12 adduct, showing the ligand which interacts via π‐stacking, sandwiched at the interface of two symmetry‐related quadruplex units, with its benzhydryl group contributing to the overall stability of the adduct by means of additional π‐stacking interactions with the DNA residues. The berberine derivatives were also investigated for their cytotoxic activity towards a panel of human cancer cell lines. Compounds NAX042 and NAX053 affect the viability of cancer cell lines in a dose‐dependent manner.     

Synthesis of Berberine and Canagliflozin Chimera and Investigation into New Antibacterial Activity and Mechanisms

Berberine is an isoquinoline alkaloid isolated from Chinese herbal medicines such as Coptis chinensis. It has many pharmacological actions, such as antibacterial, hypoglycemic, anti-inflammatory, and so on. However, due to the low lipophilicity of berberine, it is difficult to penetrate the bacterial cell membrane and also difficult to be absorbed orally and usually needs a relatively high dose to achieve the ideal effect. The purpose of this study is to transform the structure of berberine in order to improve the bioavailability of berberine and reduce the dosage. Moreover, we introduce a pharmacophore named Canagliflozin, a hypoglycemic drug (which was also found to have potential anti-bacterial activity) into BBR to see whether this new compound has more existed activities. We at first connected berberine with Canagliflozin, to form a new compound (BC) and see whether BC has synergic effects. We use microbroth dilution method to determine the minimum inhibitory concentration of BC, determine the bacterial growth with the enzyme labeling instrument, observe the formation of bacterial biofilm with crystal violet staining method, observe the bacterial morphology with field emission scanning electron microscope, and determine the intracellular protein with SDS-PAGE. The above indicators reflect the damage of BC to bacteria. New compound BC was successfully obtained by chemical synthesis. The minimal inhibitory concentration of compound BC on three bacteria was significantly better than that of berberine and canagliflozin alone and the combination of berberine and canagliflozin. Moreover, compound BC has obvious destructive effect on bacterial morphology and biofilm, and the compound also has destructive effect on intracellular proteins. Therefore, new compound BC has broad-spectrum antibacterial activity and the inhibitory effect of BC might play a role by destroying the integrity of biofilm and the intracellular protein of bacteria. In conclusion, we create a new molecular entity of berberine and Canagliflozin chimera and open up a new prospect for berberine derivatives in the treatment of bacterial infection.     

Efficient photoinduced DNA damage by coralyne

The photoinduced DNA damage by the berberine derivative coralyne is presented. The irradiation of coralyne in the presence of plasmid DNA namely, pBR322, leads to remarkably fast DNA damage by single-strand cleavage, as determined by agarose-gel electrophoresis. Even upon exposure to sunlight, almost all of the supercoiled plasmid is converted to the open circular form in less than a minute [c(pBR322) = 3.5 x 10(-9) M; c(coralyne) = 4.3 x 10(-5) M]. The efficiency of the DNA strand cleavage is not decreased in the presence of radical-trapping reagents such as tert-butanol or DMSO. Moreover, the extent of the DNA damage is the same under aerobic conditions and at reduced oxygen concentration. Thus, the formation of reactive intermediates such as hydroxyl radicals or singlet oxygen is excluded. These results show that the exposure of coralyne and derivatives thereof to light, even with moderate light intensity, needs to be avoided during experiments in which their biological activity is assessed by plasmid unwinding assays.     

6-取代喹唑啉衍生物的合成及抗肿瘤活性研究进展

喹唑啉及其衍生物作为重要的药效团,具有广谱的抗肿瘤生物活性,一直是药物化学研究的热点。本文围绕近年来6-酰胺类、卤代类、醚类、与7-位成环类、杂环类等喹唑啉衍生物的合成及其抗肿瘤活性作用机制研究进行概述,以期为活性更高、毒性更小的新型抗肿瘤化合物的设计合成提供参考。     

Discovery of Novel Sultone Fused Berberine Derivatives as Promising Tdp1 Inhibitors

A new type of berberine derivatives was obtained by the reaction of berberrubine with aliphatic sulfonyl chlorides. The new polycyclic compounds have a sultone ring condensed to C and D rings of a protoberberine core. The reaction conditions were developed to facilitate the formation of sultones with high yields without by-product formation. Thus, it was shown that the order of addition of reagents affects the composition of the reaction products: when sulfochlorides are added to berberrubine, their corresponding 9-O-sulfonates are predominantly formed; when berberrubine is added to pre-generated sulfenes, sultones are the only products. The reaction was shown to proceed stereo-selectively and the cycle configuration was confirmed by 2D NMR spectroscopy. The inhibitory activity of the synthesized sultones and their 12-brominated analogs against the DNA-repair enzyme tyrosyl-DNA phosphodiesterase 1 (Tdp1), an important target for a potential antitumor therapy, was studied. All derivatives were active in the micromolar and submicromolar range, in contrast to the acyclic analogs and 9-O-sulfonates, which were inactive. The significance of the sultone cycle and bromine substituent in binding with the enzyme was confirmed using molecular modeling. The active inhibitors are mostly non-toxic to the HeLa cancer cell line, and several ligands show synergy with topotecan, a topoisomerase 1 poison in clinical use. Thus, novel berberine derivatives can be considered as candidates for adjuvant therapy against cancer.     

Synthesis of Moracin C and Its Derivatives with a 2-arylbenzofuran Motif and Evaluation of Their PCSK9 Inhibitory Effects in HepG2 Cells

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key factor in several cardiovascular diseases, as it is responsible for the elevation of circulating low-density lipoprotein cholesterol (LDL-C) levels in blood plasma by direct interaction with the LDL receptor. The development of orally available drugs to inhibit this PCSK9-LDLR interaction is a highly desirable objective. Here, we report the synthesis of naturally occurring moracin compounds and their derivatives with a 2-arylbenzofuran motif to inhibit PCSK9 expression. In addition, we discuss a short approach involving the three-step synthesis of moracin C and a divergent method to obtain various analogs from one starting material. Among the tested derivatives, compound 7 (97.1%) was identified as a more potent inhibitor of PCSK9 expression in HepG2 cells than berberine (60.9%). These results provide a better understanding of the structure–activity relationships of moracin derivatives for the inhibition of PCSK9 expression in human hepatocytes.     

1,2,3-噻二唑-4-乙酰胺(吗啉)类衍生物的合成与生物活性

以双乙烯酮为起始原料, 设计并合成了一系列新颖的1,2,3-噻二唑-4-乙酰苯胺(吗啉)类化合物, 通过元素分析、红外光谱、核磁共振氢谱和质谱对其结构进行了表征. 生物活性测试结果表明,部分化合物具有一定的抗TMV活性、 植物生长调节活性和杀菌活性.     

鱼藤酮类衍生物的研究进展

鱼藤酮类衍生物是一类从鱼藤属等植物中提取出来的具有杀虫活性的异黄酮类化合物. 从1932年至今, 已经从植物中提取分离出47种鱼藤酮类化合物. 这一类化合物之所以具有很好的杀虫活性, 是由于对还原型烟酰胺腺嘌呤二核甘酸(NADH)的抑制作用而阻断了线粒体的呼吸. 对天然鱼藤酮类衍生物的结构、活性和合成方面的研究分别进行了概括.